Closed
SectorHealthcare
463.29 -0.04
24h
Min
459.52
Max
463.45
Income | -8.8M -66M |
|---|---|
Sales | 180M 774M |
Profit margin | -8.566 |
Employees | 2,230 |
EBITDA | 7.4M 19M |
Recommendations | Strong Buy |
|---|---|
12 Months Forecast | +3.35% upside |
Next Earnings | 30 Oct 2025 |
|---|
Market Cap | 22B 64B |
|---|---|
Previous open | 463.33 |
Previous close | 463.29 |
By Acuity
50%
50%
147 / 371 Healthcare
By Trading Central
Confidence
Bullish Evidence
Past performance is not a reliable indicator of future results.
Price change
By TipRanks
12 Months Forecast
Average 478.96 USD 3.35%
High 583 USD
Low 370 USD
Based on 26 Wall Street analysts offering 12 month price targets forAlnylam Pharmaceuticals Inc - Dist in the last 3 months.
By Acuity
News Sentiment
Neutral
Volatility
Below average
News Volume (RCV)
Average
Selling and administration expenses
Operating expenses
Pre-tax profit
Sales
Cost of sales
Gross profit on sales
Interest expense on debt
EBITDA
Operating profit
$